Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other physicians.

Stock Info

NASDAQ: SNTS
Current Price: 4.00
Change: 0.00

11/23/2009 6:44:36 AM EST
Quotes delayed 20 minutes.

Zegerid


November 10, 2009
Santarus to Present at Lazard Capital Markets 6th Annual Healthcare Conference

November 4, 2009
Santarus Reports Third Quarter 2009 Financial Results

October 26, 2009
Positive Data from Two Investigator-Initiated Studies with Santarus'' ZEGERID to Be Presented At ACG


Clinician Info
Patient Info

Careers Santarus is hiring skilled people like you. Join our team today!